Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer's disease

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder with significant global health impact.
• The amyloid cascade hypothesis, focusing on beta-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs), is widely accepted but doesn't explain all AD pathologies.
• Early AD pathologies include disrupted calcium homeostasis, lipid metabolism, mitochondrial dysfunction, and impaired autophagy.

Purpose of the Study:

• To review the role of mitochondria-associated membranes (MAMs) in regulating Alzheimer's disease (AD) pathologies.
• To explore the molecular mechanisms underlying MAM-mediated pathological changes in AD.
• To highlight the potential of targeting MAMs for novel therapeutic strategies in AD.

Main Methods:

• Literature review focusing on the role of MAMs in AD pathogenesis.
• Analysis of molecular mechanisms linking MAMs to early AD pathologies.
• Synthesis of current understanding of MAMs in relation to endoplasmic reticulum (ER) and mitochondria communication.

Main Results:

• Mitochondria-associated membranes (MAMs), connecting the ER and mitochondria, are implicated in early AD pathologies.
• Aberrant MAMs function may precede Aβ deposition and NFTs formation.
• MAMs are involved in regulating calcium homeostasis, lipid metabolism, mitochondrial function, and autophagy in the context of AD.

Conclusions:

• MAMs are critically involved in the cascade of early events leading to neurodegeneration in Alzheimer's disease.
• Understanding MAMs' role offers potential for developing preventative strategies against AD.
• Targeting MAMs could shift AD treatment paradigms from managing symptoms to preventing disease onset.